GradedHealth

Does nicotine have any benefits? What the research shows

Nicotine patches and gum raise quit rates by 50% to 60%, and lab studies find small, brief attention gains. What it can and can't do — and the risks.

Published October 2026

Short answer

Nicotine's best-supported benefit is helping smokers quit: patches and gum raise quit rates by 50% to 60%. Brain effects are small and short-lived, and nicotine is addictive — it is not a focus drug to try. Evidence grade B (Moderate). Cochrane meta-analysis of 133 trials gives the quitting benefit high certainty, but the attention findings are short-lived and mixed and the colitis trials conflict; the overall answer is downgraded to B.

Key takeaways

  • Used as patches, gum or lozenges, nicotine raises the chance of quitting smoking by 50% to 60% [1].
  • Meta-analyses of laboratory studies find small, short-lived attention gains from nicotine patches in non-smokers, with no clear memory benefit [2].
  • In ulcerative colitis, nicotine helped active flare-ups in old trials but was no better than standard treatment and did not prevent relapse [3][4].
  • Nicotine is the addictive component of tobacco, and its medicines commonly cause irritation, nausea, headache and sleep problems [5][1].

The short version

Nicotine has real but narrow benefits: as patches, gum or lozenges it raises a smoker's chance of quitting by 50% to 60%, which is its best-supported use [1]. For the brain, lab studies find small, brief improvements in attention in healthy non-smokers — not a general upgrade in thinking power [2]. Nicotine is the addictive part of tobacco, and older trials in ulcerative colitis were mixed, so the benefits come with real limits [5][3].

What the studies show

The strongest evidence is for quitting smoking. A Cochrane review pooled 133 randomised trials with 64,640 smokers and found that every licensed form of nicotine replacement — patch, gum, lozenge, spray and inhalator — raised long-term quitting compared with placebo or no help, with a pooled risk ratio of 1.55; the review describes this as raising the rate of quitting by 50% to 60% [1]. The effect held across settings, and extra support helps but is not essential [1].

Does nicotine sharpen the mind? A 2021 meta-analysis of 31 laboratory studies in 978 healthy non-smoking adults found nicotine patches improved overall cognitive test scores and attention, with small effect sizes of about 0.23 standard deviations; memory improvements were not statistically significant [2]. An earlier meta-analysis of 41 double-blind laboratory studies found small positive effects on six of nine performance areas, including attention, fine motor skills and short-term memory, with effect sizes of 0.16 to 0.44 [6]. The gains are not universal: in a trial of 62 non-smoking men, a 7 mg patch improved sustained attention mainly in those who started with lower attention scores, and slightly impaired strategy learning in highly attentive men [7].

People with attention problems may gain more. Small trials found nicotine improved response inhibition in 15 young non-smoking adults with ADHD [8] and lowered symptom severity in 40 adults [9], and a systematic review of 29 studies in people with schizophrenia found single doses improved attention, working memory and executive function [10]. These are short laboratory experiments in small groups [8][10].

In ulcerative colitis, older trials showed promise: in a six-week study of 72 people, 17 of 35 on nicotine patches reached complete remission versus 9 of 37 on placebo [11]. But nicotine was no better than standard steroid or mesalazine treatment [3], nicotine enemas did not work in a 104-person trial [12], it did not prevent relapse over six months [4], and a 2010 meta-analysis found no significant remission benefit while confirming more side effects [13]. It never became a standard treatment [13].

The nuances

Nicotine is addictive: it is the major reinforcing component of tobacco smoke, acting on nicotinic receptors in the brain [5]. The attention studies measured test performance in single laboratory sessions, not memory or thinking in daily life [2]. For smokers trying to quit, that short-term help is welcome; for everyone else, the trade-off is harder.

Side effects of nicotine medicines are common: skin irritation from patches, mouth irritation from gum and lozenges, and nausea, lightheadedness, headache and sleep problems [1][11]. Chest pain or palpitations are uncommon but more frequent than with placebo — about 1.9 times the odds — and serious heart events are extremely rare, even in people with existing heart disease [1][14]. High doses are poisonous: swallowing e-liquid can cause severe, potentially fatal poisoning, and nicotine poisoning follows a two-phase pattern — first abdominal pain, high blood pressure, fast heart rate and tremors, then low blood pressure, slow heart rate and breathing trouble [15][16].

What this means for you

If you smoke and want to stop, nicotine replacement is one of the best-supported tools available: it raises quit rates even without intensive counselling, though extra support helps [1]. If you do not use tobacco, nicotine is not a shortcut to focus — the attention gains are small, brief and come from the drug that hooks smokers [2][5]. Pregnant women and people with heart disease should ask a doctor or pharmacist before using nicotine medicines [17][14].

Go deeper

  • Nicotine — As a medicine, nicotine's best-supported benefit is helping smokers quit: patches, gum and other forms raise quit rates by 50% to 60%.

References

  1. Nicotine replacement therapy versus control for smoking cessation.. Cochrane Database Syst Rev, 2018.
  2. Effects of transdermal nicotine delivery on cognitive outcomes: A meta-analysis.. Acta Neurol Scand, 2021.
  3. Transdermal nicotine for induction of remission in ulcerative colitis.. Cochrane Database Syst Rev, 2004.
  4. Transdermal nicotine as maintenance therapy for ulcerative colitis.. N Engl J Med, 1995.
  5. Mechanisms of Nicotine Addiction.. Cold Spring Harb Perspect Med, 2021.
  6. Meta-analysis of the acute effects of nicotine and smoking on human performance.. Psychopharmacology (Berl), 2010.
  7. Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits.. Physiol Behav, 2006.
  8. Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder.. Pharmacol Biochem Behav, 2008.
  9. Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder.. Exp Clin Psychopharmacol, 2001.
  10. The effects of acute nicotine administration on cognitive and early sensory processes in schizophrenia: a systematic review.. Neurosci Biobehav Rev, 2020.
  11. Transdermal nicotine for active ulcerative colitis.. N Engl J Med, 1994.
  12. A randomized trial of nicotine enemas for active ulcerative colitis.. Clin Gastroenterol Hepatol, 2005.
  13. Systematic review and meta-analysis of the efficacy and tolerability of nicotine preparations in active ulcerative colitis.. Clin Ther, 2010.
  14. Cardiac adverse effects of nicotine replacement therapy.. Prescrire Int, 2015.
  15. Severe neurological nicotine intoxication by e-cigarette liquids: Systematic literature review.. Acta Neurol Scand, 2021.
  16. Nicotinic plant poisoning.. Clin Toxicol (Phila), 2009.
  17. Fetal safety of nicotine replacement therapy in pregnancy: systematic review and meta-analysis.. Addiction, 2021.